Next-generation metabolomics may facilitate the discovery of new antidepressants

(Bentham Science Publishers) Antidepressants have become one of the most commonly prescribed drugs. With the technical advances in analytical instruments, metabolomics is entering into a 'next generation' phase. Dr. Li and colleagues from the University of California, San Diego, USA have summarized the analytical platforms of next-generation metabolomics (NGM) and its main applications in antidepressant R&D. In particular, they demonstrate the low toxicity and multi-targets of albiflorin using N...